Doptelet® (avatrombopag) receives positive opinion from CHMP for treatment of ITP ...Middle East

PR Newswire - News
Doptelet® (avatrombopag) receives positive opinion from CHMP for treatment of ITP
STOCKHOLM, Dec. 11, 2020 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi™) (STO:SOBI) today announces that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of Doptelet® (avatrombopag) for the treatment...

Hence then, the article about doptelet avatrombopag receives positive opinion from chmp for treatment of itp was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Doptelet® (avatrombopag) receives positive opinion from CHMP for treatment of ITP )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News